These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Benefit versus risk factors in immunization against yellow fever. Brès P Dev Biol Stand; 1979; 43():297-304. PubMed ID: 574841 [No Abstract] [Full Text] [Related]
8. Yellow fever, 1996-1997. Part II. Wkly Epidemiol Rec; 1998 Nov; 73(47):370-2. PubMed ID: 9844551 [No Abstract] [Full Text] [Related]
9. Inadequate protection against yellow fever of children visiting endemic areas. Potasman I; Pick N; Stringer C; Zuckerman JN Am J Trop Med Hyg; 2001 Dec; 65(6):954-7. PubMed ID: 11792005 [TBL] [Abstract][Full Text] [Related]
10. Administration of time-expired yellow fever vaccine: public health response and results of a serological investigation. Allen KW; Nguyen-Van-Tam JS; Howells J Commun Dis Public Health; 1999 Jun; 2(2):141-2. PubMed ID: 10402751 [TBL] [Abstract][Full Text] [Related]
11. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937). Theiler M; Smith HH Rev Med Virol; 2000; 10(1):6-16; discussion 3-5. PubMed ID: 10654001 [No Abstract] [Full Text] [Related]
12. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment. Cane PA; Gould EA J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449 [TBL] [Abstract][Full Text] [Related]